伏立诺他
光热治疗
半胱氨酸
铜
程序性细胞死亡
癌症研究
骨肉瘤
化学
医学
细胞凋亡
生物化学
材料科学
纳米技术
组蛋白
组蛋白脱乙酰基酶
酶
有机化学
基因
作者
Sizhen Wang,Hanzhe Zhang,Tianheng Chen,Weiwei Jiang,Feng Wang,Yuhao Yu,Beibei Guo,Jia Ming Xu,Feng Yang,Qinglin Kang,Zhiqiang Ma
标识
DOI:10.1016/j.mtbio.2024.101368
摘要
The prognosis for osteosarcoma patients, a devastating malignancy affecting young individuals, remains grim despite multimodal therapeutic advances. Recently, the advent of cuproptosis, a novel programmed cell death, offers hope in fighting osteosarcoma. In this study, we introduce SAHA m @{[Cu(HA-Cys) 2 ]Cl 2 } n , an injectable hyaluronate-L-cysteine hydrogel that integrates both copper ions (Cu 2+ ) and vorinostat (SAHA) for the possible therapeutic effect. The Cu 2+ targets the TCA cycle, inducing cuproptosis in osteosarcoma cells. While SAHA acts as both a histone deacetylase inhibitor and an ROS generator for eliminating tumor cells. The mechanism involves amplifying FDX-1 expression via SAHA modulation of the TCA cycle, which was an original discovery. Critically, the combined mechanisms and localized injection enables the hydrogel partially eradicating osteosarcoma without metastasis in rats. Therefore, this study advances cuproptosis induced photothermal therapy for promising clinical translations, shedding light on favorable prognosis for osteosarcoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI